Advanced BRAF Mutant Cancers
2 clinical trials · Condition
◉ Watch Advanced BRAF Mutant Cancers
| Record | Firm | Date |
|---|---|---|
| A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers (NCT03843775) | Memorial Sloan Kettering Cancer Center | 2019-02-14 |
| Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma (NCT01616199) | Cascadian Therapeutics Inc. | 2012-08-01 |
Track Advanced BRAF Mutant Cancers automatically
Every clearance here is in the API, with alerts when new ones post.